flecainide has been researched along with Peripheral Nerve Diseases in 6 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
Excerpt | Relevance | Reference |
---|---|---|
"Flecainide was used to treat malignant neuropathic pain but despite using therapeutic doses, toxicity occurred resulting in paranoid psychosis." | 7.69 | Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain. ( Bennett, MI, 1997) |
"Flecainide was used to treat malignant neuropathic pain but despite using therapeutic doses, toxicity occurred resulting in paranoid psychosis." | 3.69 | Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain. ( Bennett, MI, 1997) |
"Flecainide acetate is a classic Ic antiarrhythmic agent used to treat a variety of cardiac arrhythmias." | 1.38 | Skin biopsy-proven flecainide-induced neuropathy. ( Burakgazi, AZ; Höke, A; Polydefkis, M, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wu, C | 1 |
Tcherny-Lessenot, S | 1 |
Dai, W | 1 |
Wang, Y | 1 |
Kechemir, H | 1 |
Gandhi, S | 1 |
Lin, S | 1 |
Juhaeri, J | 1 |
Burakgazi, AZ | 1 |
Polydefkis, M | 1 |
Höke, A | 1 |
Malesker, MA | 1 |
Sojka, SG | 1 |
Fagan, NL | 1 |
Bennett, MI | 1 |
Ichimata, M | 1 |
Kitano, T | 1 |
Ikebe, H | 1 |
Iwasaka, H | 1 |
Noguchi, T | 1 |
Palace, J | 1 |
Shah, R | 1 |
Clough, C | 1 |
6 other studies available for flecainide and Peripheral Nerve Diseases
Article | Year |
---|---|
Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Stud | 2018 |
Skin biopsy-proven flecainide-induced neuropathy.
Topics: Aged; Anti-Arrhythmia Agents; Biopsy; Flecainide; Humans; Male; Peripheral Nervous System Diseases; | 2012 |
Flecainide-induced neuropathy.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Flecainide; Gait Disorders, Neurologic; | 2005 |
Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain.
Topics: Anti-Arrhythmia Agents; Brachial Plexus; Flecainide; Humans; Male; Middle Aged; Pain; Palliative Car | 1997 |
Flecainide reverses neuropathic pain and suppresses ectopic nerve discharge in rats.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationsh | 2001 |
Flecainide induced peripheral neuropathy.
Topics: Flecainide; Humans; Male; Middle Aged; Peripheral Nervous System Diseases | 1992 |